Factor | Fatigue | Pain interference | ||||||
Slope* (±SE) (per 1-point ↑) | Slope (per 5-point ↑) | P value | MSE | Slope* (±SE) (per 1-point ↑) | Slope (per 5-point ↑) | P value | MSE | |
Univariate | ||||||||
Symptom self-efficacy | −0.556±0.044 | −2.781 | <0.001 | 97.4 | −0.394±0.042 | −1.971 | <0.001 | 87.4 |
Treatment self-efficacy | −0.282±0.044 | −1.411 | <0.001 | 113.4 | −0.152±0.041 | −0.760 | <0.001 | 96.7 |
Multiple† | ||||||||
Symptom self-efficacy | −0.241±0.043 | −1.204 | <0.001 | 66.9 | −0.103±0.040 | −0.537 | 0.008 | 59.9 |
Treatment self-efficacy | −0.072±0.038 | −0.360 | 0.055 | 70.0 | 0.025±0.035 | 0.127 | 0.47 | 60.6 |
*Indicates b regression coefficient.
†Adjusted for age, disease duration, education, work status, insurance, depression, disease activity (SLAQ) and organ damage (SA-BILD).
MSE, mean square error; SA-BILD, Self-Administered Brief Index of Lupus Damage; SLAQ, Systemic Lupus Activity Questionnaire.